Ignite Creation Date:
2025-12-24 @ 2:17 PM
Ignite Modification Date:
2026-02-21 @ 9:56 PM
Study NCT ID:
NCT03880695
Status:
UNKNOWN
Last Update Posted:
2019-03-21
First Post:
2019-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
Sponsor:
Peking University People's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-05
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-14
First Submit QC Date:
None
Study First Post Date:
2019-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-19
Last Update Post Date:
2019-03-21
Last Update Post Date Type:
ACTUAL